ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Cancer Policy; Board Suggests More Detailed Items In Tobacco Agreement

August 22, 1997

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002